Periodontal Medicaments

Periodontal diseases often require adjunctive therapies to traditional mechanical treatments such as scaling and root planing. Various medicaments have been developed to enhance the healing process and control infection in periodontal tissues.

1. Elyzol

• Composition:
  • Elyzol is an oil-based gel containing 25% metronidazole. It is formulated with glyceryl mono-oleate and sesame oil.
• Clinical Use:
  • Elyzol has been found to be equivalent to scaling and root planing in terms of effectiveness for treating periodontal disease.
  • However, no adjunctive effects beyond those achieved with mechanical debridement have been demonstrated.

2. Actisite

• Composition:

  • Actisite consists of tetracycline-containing fibers.
  • Each fiber has a diameter of 0.5 mm and contains 12.7 mg of tetracycline per 9 inches of fiber.

• Clinical Use:

  • The fibers are placed directly into periodontal pockets, where they release tetracycline over time, helping to reduce bacterial load and promote healing.

3. Arestin

• Composition:

  • Arestin contains minocycline, which is delivered as a biodegradable powder in a syringe.

• Clinical Use:

  • Arestin is indicated for the treatment of periodontal disease and is applied directly into periodontal pockets, where it provides localized antibiotic therapy.

4. Atridox

• Composition:

  • Atridox contains 10% doxycycline in a syringeable gel system that is biodegradable.

• Clinical Use:

  • The gel is injected into periodontal pockets, where it solidifies and releases doxycycline over time, aiding in the management of periodontal disease.

5. Dentamycin and Periocline

• Composition:

  • Both Dentamycin and Periocline contain 2% minocycline hydrochloride.

• Clinical Use:

  • These products are used similarly to other local delivery systems, providing localized antibiotic therapy to reduce bacterial infection in periodontal pockets.

6. Periochip

• Composition:

  • Periochip is a biodegradable chip that contains chlorhexidine.

• Clinical Use:

  • The chip is placed in the gingival crevice, where it releases chlorhexidine over time, providing antimicrobial action and helping to control periodontal disease.

🔬 Key Features & Forms

• Most infective form: Cavitary lesion
• Primary TB Presentation: Unilateral hilar lymphadenopathy
• Rich focus: Meninges (associated with TB meningitis)
• Cavitation: Absent in HIV-associated or primary TB

💡 Special Manifestations

• Hypersensitivity to Mycobacteria: Phlyctenular conjunctivitis
• Poncet’s disease: Joint pains without active arthritis
• Miliary TB: Mantoux test negative
• Recurrent hemoptysis source: Bronchial artery

💊 Drug Details

• Streptomycin: Not used in TB meningitis
• Bedaquiline: New drug for MDR-TB

Diagnosis Criteria

• FBS ≥ 126 mg/dL
• HbA1C > 6.5%
• eAG based on HbA1C
• Oral GTT 2-hr post-load: 140–199 mg/dL → Impaired Glucose Tolerance
• HbA1C 5.7–6.4% → Pre-diabetic range

High-Yield Numbers

• FBS ≥126 mg/dL (DM diagnosis)
• HbA1C >6.5% (DM diagnosis)
• IGT: 140-199 mg/dL (2-hr GTT)
• Sleep apnea: ≥10 seconds
• Cortisol <3 mg/dL (Addison's)
• ACTH >200 pg/mL (Addison's)
• Nebulizer droplets <2.5 μm

Remember the "Onlys"

• Telmisartan: Only ARB with PPAR-γ activity
• Microalbuminuria: Most reliable diabetic nephropathy marker
• TB: Most common cause of adrenal insufficiency in India
• Melanoma: Most common primary tumor → adrenal mets

Classic Associations

• Type 1 DM: HLA-DR3/DR4, Anti-GAD antibodies
• Aspirin asthma: Nasal polyps
• Emphysema: Weight loss, pneumothorax, ↓DLCO
• Chronic bronchitis: Polycythemia, Reid's index

Assessing New Attachment in Periodontal Therapy

Assessing new attachment following periodontal therapy is crucial for evaluating treatment outcomes and understanding the healing process. However, various methods of assessment have limitations that must be considered.

1. Periodontal Probing

• Assessment Method: Periodontal probing is commonly used to measure probing depth and attachment levels before and after therapy.

• Limitations:

  • Coronal Positioning of Probe Tip: After therapy, when the inflammatory lesion is resolved, the probe tip may stop coronal to the apical termination of the epithelium. This can lead to misleading interpretations of attachment gain.
  • Infrabony Defects: Following treatment of infrabony defects, new bone may form so close to the tooth surface that the probe cannot penetrate. This can result in a false impression of improved attachment levels.
  • Interpretation of Results: A gain in probing attachment level does not necessarily indicate a true gain of connective tissue attachment. Instead, it may reflect improved health of the surrounding tissues, which increases resistance to probe penetration.

2. Radiographic Analysis and Reentry Operations

• Assessment Method: Radiographic analysis involves comparing radiographs taken before and after therapy to evaluate changes in bone levels. Reentry operations allow for direct inspection of the treated area.

• Limitations:

  • Bone Fill vs. New Attachment: While radiographs can provide evidence of new bone formation (bone fill), they do not document the formation of new root cementum or a new periodontal ligament. Therefore, radiographic evidence alone cannot confirm the establishment of new attachment.

3. Histologic Methods

• Assessment Method: Histologic analysis involves examining tissue samples under a microscope to assess the formation of new attachment, including new cementum and periodontal ligament.

• Advantages:

  • Validity: Histologic methods are considered the only valid approach to assess the formation of new attachment accurately.

• Limitations:

  • Pre-Therapy Assessment: Accurate assessment of the attachment level prior to therapy is essential for histologic analysis. If the initial attachment level cannot be determined with certainty, it may compromise the validity of the findings.

Periodontal Medications and Their Uses

Periodontal medications play a crucial role in the management of periodontal diseases, aiding in the treatment of infections, inflammation, and tissue regeneration. Understanding the various types of medications and their specific uses is essential for effective periodontal therapy.

Types of Periodontal Medications

1. Antibiotics:

   • Uses:
     • Used to treat bacterial infections associated with periodontal disease.
     • Commonly prescribed antibiotics include amoxicillin, metronidazole, and doxycycline.
   • Mechanism:
     • They help reduce the bacterial load in periodontal pockets, promoting healing and reducing inflammation.

2. Antimicrobial Agents:

   • Chlorhexidine:
     • Uses: A topical antiseptic used as a mouth rinse to reduce plaque and gingivitis.
     • Mechanism: It disrupts bacterial cell membranes and inhibits bacterial growth.
   • Tetracycline:
     • Uses: Can be used topically in periodontal pockets to reduce bacteria.
     • Mechanism: Inhibits protein synthesis in bacteria, reducing their ability to cause infection.

3. Anti-Inflammatory Medications:

   • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs):
     • Uses: Used to manage pain and inflammation associated with periodontal disease.
     • Examples: Ibuprofen and naproxen.
   • Corticosteroids:
     • Uses: May be used in severe cases to reduce inflammation.
     • Mechanism: Suppress the immune response and reduce inflammation.

4. Local Delivery Systems:

   • Doxycycline Gel (Atridox):
     • Uses: A biodegradable gel that releases doxycycline directly into periodontal pockets.
     • Mechanism: Provides localized antibiotic therapy to reduce bacteria and inflammation.
   • Minocycline Microspheres (Arestin):
     • Uses: A localized antibiotic treatment that is placed directly into periodontal pockets.
     • Mechanism: Releases minocycline over time to combat infection.

5. Regenerative Agents:

   • Bone Grafts and Guided Tissue Regeneration (GTR) Materials:
     • Uses: Used in surgical procedures to promote the regeneration of lost periodontal tissues.
     • Mechanism: Provide a scaffold for new tissue growth and prevent the ingrowth of epithelium into the defect.

6. Desensitizing Agents:

   • Fluoride Varnishes:
     • Uses: Applied to sensitive areas to reduce sensitivity and promote remineralization.
     • Mechanism: Strengthens enamel and reduces sensitivity by occluding dentinal tubules.

Clinical Significance of Periodontal Medications

1. Management of Periodontal Disease:

   • Medications are essential in controlling infections and inflammation, which are critical for the successful treatment of periodontal diseases.

2. Adjunct to Non-Surgical Therapy:

   • Periodontal medications can enhance the effectiveness of non-surgical treatments, such as scaling and root planing, by reducing bacterial load and inflammation.

3. Surgical Interventions:

   • In surgical procedures, medications can aid in healing and regeneration, improving outcomes for patients undergoing periodontal surgery.

4. Patient Compliance:

   • Educating patients about the importance of medications in their treatment plan can improve compliance and overall treatment success.